Literature DB >> 9329961

Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow.

S C Lin1, T Yamate, Y Taguchi, V Z Borba, G Girasole, C A O'Brien, T Bellido, E Abe, S C Manolagas.   

Abstract

Both estrogen and androgen exert their antiosteoporotic effects, at least in part, by inhibiting IL-6 production, thereby suppressing osteoclastogenesis. Several observations, however, suggest that besides increased IL-6 production, sensitivity of the osteoclastogenic process to this cytokine is altered after ovariectomy. Based on this and evidence that the ligand-binding subunit of the IL-6 receptor (gp80) is a limiting factor for the actions of IL-6 on bone, we hypothesized that sex steroids regulate expression of the IL-6 receptor as well. We report that 17beta-estradiol or dihydrotestosterone in vitro decreased the abundance of the gp80 mRNA as well as the mRNA of the signal-transducing subunit of the IL-6 receptor (gp130) in cells of the bone marrow stromal/osteoblastic lineage, and also decreased gp130 protein levels. These effects did not require new protein synthesis. In contrast to sex steroids, parathyroid hormone stimulated gp130 expression; this effect was opposed by sex steroids. Consistent with these findings, ovariectomy in mice caused an increase in expression of gp80, gp130, and IL-6 mRNAs in ex vivo bone marrow cell cultures as determined by quantitative reverse transcription (RT)-PCR, and confirmed on an individual cell basis using in situ RT-PCR. The demonstration of increased expression of the IL-6 receptor after loss of sex steroids provides an explanation for why IL-6 is important for skeletal homeostasis in the sex steroid-deficient, but not replete, state.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9329961      PMCID: PMC508387          DOI: 10.1172/JCI119729

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.

Authors:  S Kotake; K Sato; K J Kim; N Takahashi; N Udagawa; I Nakamura; A Yamaguchi; T Kishimoto; T Suda; S Kashiwazaki
Journal:  J Bone Miner Res       Date:  1996-01       Impact factor: 6.741

Review 2.  Cytokine signal transduction.

Authors:  T Kishimoto; T Taga; S Akira
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

3.  Interleukin-11: a new cytokine critical for osteoclast development.

Authors:  G Girasole; G Passeri; R L Jilka; S C Manolagas
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

4.  Stimulation of interleukin-6 production by either calcitonin gene-related peptide or parathyroid hormone in two phenotypically distinct bone marrow-derived murine stromal cell lines.

Authors:  Y Sakagami; G Girasole; X P Yu; H S Boswell; S C Manolagas
Journal:  J Bone Miner Res       Date:  1993-07       Impact factor: 6.741

5.  Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal.

Authors:  G Passeri; G Girasole; R L Jilka; S C Manolagas
Journal:  Endocrinology       Date:  1993-08       Impact factor: 4.736

6.  Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6.

Authors:  Z Zhong; Z Wen; J E Darnell
Journal:  Science       Date:  1994-04-01       Impact factor: 47.728

7.  Cross-linking identifies leukemia inhibitory factor-binding protein as a ciliary neurotrophic factor receptor component.

Authors:  N Stahl; S Davis; V Wong; T Taga; T Kishimoto; N Y Ip; G D Yancopoulos
Journal:  J Biol Chem       Date:  1993-04-15       Impact factor: 5.157

8.  Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.

Authors:  T Tamura; N Udagawa; N Takahashi; C Miyaura; S Tanaka; Y Yamada; Y Koishihara; Y Ohsugi; K Kumaki; T Taga
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

9.  17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism.

Authors:  S T Pottratz; T Bellido; H Mocharla; D Crabb; S C Manolagas
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

10.  Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.

Authors:  V Poli; R Balena; E Fattori; A Markatos; M Yamamoto; H Tanaka; G Ciliberto; G A Rodan; F Costantini
Journal:  EMBO J       Date:  1994-03-01       Impact factor: 11.598

View more
  15 in total

1.  Redox regulation of the proteasome in T lymphocytes during aging.

Authors:  Rupali Das; Subramaniam Ponnappan; Usha Ponnappan
Journal:  Free Radic Biol Med       Date:  2006-11-23       Impact factor: 7.376

Review 2.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

3.  Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption.

Authors:  R L Jilka; K Takahashi; M Munshi; D C Williams; P K Roberson; S C Manolagas
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

4.  Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130.

Authors:  Masahiko Hayashi; Mun-Chual Rho; Akiko Enomoto; Akiko Fukami; Yong-Pil Kim; Yuji Kikuchi; Toshiaki Sunazuka; Tomoyasu Hirose; Kanki Komiyama; Satoshi Omura
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

5.  Effects of 17beta-estradiol on the expression of IL-6, IL-11 and NF-kappaB in human MG-63 osteoblast-like cell line.

Authors:  Yunlin Wang; Eyuan Liao; Guangda Xiang; Ruchun Dai; Xinhua Xiao; Xianghang Luo
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

6.  Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice.

Authors:  Emma C Walker; Narelle E McGregor; Ingrid J Poulton; Melissa Solano; Sueli Pompolo; Tania J Fernandes; Matthew J Constable; Geoff C Nicholson; Jian-Guo Zhang; Nicos A Nicola; Matthew T Gillespie; T John Martin; Natalie A Sims
Journal:  J Clin Invest       Date:  2010-01-04       Impact factor: 14.808

7.  Proteasome inhibition up-regulates inflammatory gene transcription induced by an atypical pathway of NF-kappaB activation.

Authors:  Sarah J Cullen; Subramaniam Ponnappan; Usha Ponnappan
Journal:  Biochem Pharmacol       Date:  2009-10-14       Impact factor: 5.858

8.  Commitment to the osteoblast lineage is not required for RANKL gene expression.

Authors:  Carlo Galli; Qiang Fu; Wenfang Wang; Bjorn R Olsen; Stavros C Manolagas; Robert L Jilka; Charles A O'Brien
Journal:  J Biol Chem       Date:  2009-03-11       Impact factor: 5.157

9.  Catalytic activity of the proteasome fine-tunes Brg1-mediated chromatin remodeling to regulate the expression of inflammatory genes.

Authors:  Sarah J Cullen; Subramaniam Ponnappan; Usha Ponnappan
Journal:  Mol Immunol       Date:  2009-10-01       Impact factor: 4.407

10.  Ovariectomy Activates Chronic Low-Grade Inflammation Mediated by Memory T Cells, Which Promotes Osteoporosis in Mice.

Authors:  Anna Cline-Smith; Ariel Axelbaum; Elena Shashkova; Mousumi Chakraborty; Jessie Sanford; Prabhjyot Panesar; Macey Peterson; Linda Cox; Angel Baldan; Deborah Veis; Rajeev Aurora
Journal:  J Bone Miner Res       Date:  2020-02-25       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.